Innoviva, Inc. Common Stock

INVANASDAQ • USD
20.66 USD
↘ 0.40 (1.90%)AT CLOSE (03:59 PM EDT)
20.65
↘ 0.01 (0.05%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
20.65
↘ 0.01 (0.05%)
🔴Market: CLOSED

Innoviva, Inc. Common Stock (INVA) is currently trading at $20.66. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, exceptional Return on Equity (29.0%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, INVA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 23, 2026.

Open?$20.88
High?$20.94
Low?$20.51
Prev. Close?$21.06
Volume?978.6K
Avg. Volume?895.9K
VWAP?$20.65
Rel. Volume?1.09x
Bid / Ask
Bid?$19.95 × 100
Ask?$21.60 × 1.0K
Spread?$1.65
Midpoint?$20.78
Valuation & Ratios
Market Cap?1.5B
Shares Out?72.2M
Float?68.9M
Float %?95.4%
P/E Ratio?4.18
P/B Ratio?1.21
EPS?$4.94
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Employees
159
Market Cap
1.5B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2004-10-05
Address
1350 OLD BAYSHORE HIGHWAY
BURLINGAME, CA 94010
Phone: (650) 238-9600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
79
Momentum?
95
Short Sent.?
60
Piotroski F-Score?4/9Mixed
Altman Z-Score?3.29Safe
Confidence?61%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.94%Elevated
Short Interest?6.8M
Days to Cover?5.7
Free Float68.9M
Avg Daily Volume1.2M
Settlement Date2026-09-30
Financial Health
Current Ratio?16.01Strong
Quick Ratio?15.18Strong
Cash Ratio?12.12Strong
Debt/Equity?0.21Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
94/100
P/E?
Peers
100
S&P
97
4.2CHEAP▾
P/B?
Peers
100
S&P
93
1.21CHEAP▾
P/S?
Peers
100
S&P
45
3.39FAIR▾
P/FCF?
Peers
100
S&P
93
7.9CHEAP▾
EV/EBITDA?
Peers
100
S&P
97
6.2CHEAP▾
EV/Sales?
Peers
100
S&P
65
2.69CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
78
29.0%STRONG▾
ROA?
Peers
50
S&P
97
21.0%STRONG▾
Cash Flow & Enterprise
FCF?$189.4M
Enterprise Value?$1.2B
Fundamentals ratios updated end of day